Impact of a novel mutation in the 5′-flanking region of natriuretic peptide precursor B gene on the antihypertensive effects of sodium nitroprusside in patients with hypertension-Reference-Cited by-同舟云学术

Impact of a novel mutation in the 5′-flanking region of natriuretic peptide precursor B gene on the antihypertensive effects of sodium nitroprusside in patients with hypertension

Published:2012-06-14 Issue:4 Volume:27 Page:271-276
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Zeng K,Wu X-d,Liu Q-c,Gao F,Lin C-z

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/jhh201225.pdf

Reference31 articles.

1. Filigheddu F, Troffa C, Glorioso N . Pharmacogenomics of essential hypertension: are we going the right way. Cardiovasc Hematol Agents Med Chem 2006; 4: 7–15.

2. Arnett DK, Claas SA, Glasser SP . Pharmacogenetics of antihypertensive treatment. Vascul Pharmacol 2006; 44: 107–118.

3. Jones DS, Perlis RH . Pharmacogenetics, race, and psychiatry prospects and challenges. Harv Rev Psychiatry 2006; 14: 92–108.

4. Schelleman H, St ricker BH, De Boer A, Kroon AA, Verschuren MW, Van Duijn CM et al. Drug gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs 2004; 64: 801–816.

5. Nakagawa K, Ishizaki T . Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine. Pharmacol Ther 2000; 86: 1–28.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The underlying mechanism of transcription factor IRF1, PRDM1, and ZNF263 involved in the regulation of NPPB rs3753581 on pulse pressure hypertension;Gene;2023-08

2. Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor;PLOS ONE;2017-05-08